Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW – DEA Announces Plan to License More Marijuana Producers for Research

In a move that’s sure to lift some moods in these trying times, the Drug Enforcement Administration (DEA) recently announced that it will be taking steps to expand the scope of marijuana research. The rule changes proposed by the agency will allow it to approve additional cannabis growers and diversify the types of marijuana available for use in studies.

“The Drug Enforcement Administration continues to support additional research into marijuana and its components, and we believe registering more growers will advance the scientific and medical research already being conducted,” said the Acting Administrator Uttam Dhillon in a press release.

“DEA is making progress to register additional marijuana growers for federally authorized research, and will continue to work with other relevant federal agencies to expedite the necessary next steps.”

Back in 2016, the DEA announced that it was accepting applications for additional marijuana manufacturers, and 37 institutions submitted their applications. However, the agency was slow to review the applications, and one of the applicants filed and won a lawsuit that mandated the DEA to take action.

The DEA argued that the high volume of applications, coupled with the complications arising from international drug treaties which the U.S. is a party to, meant they would have to develop new regulations before approving the applications.

“This is an important step and a byproduct of the legal action we filed last summer. The agency indicated it would propose new rules to govern approving new applicants to manufacture marijuana for research, and these appear to be those rules,” says Sue Sisley, a researcher with the institution that filed the lawsuit.

For countries growing cannabis for research to comply with United Nations rules, they have to meet five requirements. Currently, the DEA follows three of the requirements, but the proposed rule would amend the agency’s regulations so that the DEA directly carries out the two remaining requirements.

They are; requiring cultivators to deliver their cannabis directly to a government agency in a timely manner, but no longer than four months after harvest, and; ensuring that the agency holds the “exclusive rights of importing, exporting, wholesale trading, and maintaining stocks of cannabis and cannabis resin,” except as it concerns medical marijuana preparations.

As per the DEA’s notice, the agency “may accept delivery and maintain possession of such crops at the registered location of the registered manufacturer authorized to cultivate cannabis consistent with the maintenance of effective controls against diversion.”

The notice states that in such cases, the DEA shall designate a secure storage mechanism at the registered location in which the DEA may maintain possession of the cannabis, and the DEA will control access to the stored cannabis.” It will also control importing, exporting, wholesale trading, and maintaining stocks, and it may “exercise its exclusive rights by authorizing the performance of such activities by appropriately registered persons.”

This news that more growers are about to be federally licensed is likely to be welcomed by sector players like Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) who would like to see more research being done by the academia and other entities whose findings will not be doubted by the public.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) to Participate in Life Sciences Investor Forum’s Virtual Conference

Life Sciences Investor Forum today announced the schedule for its inaugural event for both public and private companies, investors and worldwide industry professionals. The one-day event is kicking off on Thursday, March 26 with the first live webcast at 9:30 AM ET. Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, is scheduled to provide a presentation at 12:00 PM ET on March 26. Per the release, pre-registration is recommended for investors and it is encouraged that they run the online system check to expedite participation and receive event updates. There is no cost to view the live presentations or ask questions.

To register now, visit http://cnw.fm/ArT8l

To view the full press release, visit http://cnw.fm/jc2vH

About Lexaria Bioscience

Lexaria Bioscience Corp. is a global innovator in drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way API’s enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bio-absorption; reduces time of onset; and can reduce drug costs for orally administered bioactive molecules including nicotine, vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”) and other molecules. Lexaria has licensed DehydraTECH to multiple companies for use in various oral application formats, including to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXX

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – No Borders, Inc.’s (NBDR) MediDent Supplies Announces New Stay at Home 15 Minute Rapid Result COVID-19 Blood Tests

No Borders (OTC: NBDR) on Monday announced that the Company has executed an agreement with its existing suppliers in Hong Kong to bring its 15 minute “At Home” Serological COVID-19 test to the USA. According to the update, the brand new “MediDent Supplies 15 Minute Rapid Result Covid-19 Test” is being manufactured by a MediDent Supplies partner with existing U.S. FDA registrations for both the manufacturer and the serological test kit itself. MediDent Supplies is actively engaged with the FDA to obtain an Emergency Use Authorization for its COVID-19 blood test and believes it will receive expedited approval due to a recent update to the FDA COVID-19 testing guidelines, which now include serological testing. “Our entire team is committed to deploying every ounce of effort we can to help America through this trying time,” MediDent Supplies CEO Joseph Snyder said in the news release. “Millions of people around the world have used these serological tests to identify COVID-19 antibodies in the blood and these tests will have a dramatic impact on America’s ability to scale national real time testing efforts with a proven, effective blood test.”

To view the full press release, visit http://cnw.fm/YpMt6

About No Borders Inc.

No Borders, Inc. (OTC: NBDR) is a multifaceted corporation specializing in the acquisition, creation, and scaling of commercial and consumer products by utilizing cutting-edge technologies to reduce costs while increasing revenues and shareholder value through technological superiority and Intellectual Property ownership across its portfolio of assets. The Company’s portfolio of brands includes:

No Borders Naturals Inc., a purveyor of health and wellness products for active consumers and their pets (NoBordersNaturals.com).
No Borders Labs Inc., which provides leading-edge tech tools to NBDR internal companies while also offering consulting, architecture and software development services to external businesses looking to update their technology infrastructure for greater efficiency, security, and transparency (NoBordersLabs.com).
CBDLabChain.com a powerful, Patent Pending tool to demonstrate in an unbiased and unchangeable way a clear sense of security to consumers of CBD products by recording Certificate of Authority (COA) on a blockchain technology platform.
No Borders Dental Resources Inc., a provider of equipment and supplies to medical and dental professionals across the U.S. through the trade name MediDent Supplies (MediDentSupplies.com).

No Borders is headquartered in Arizona with resources in the U.S., South America, Asia, and Europe. For more information, visit the Company’s website at www.NBDR.co.

NOTE TO INVESTORS: The latest news and updates relating to NBDR are available in the company’s newsroom at http://cnw.fm/NBDR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW – Marijuana Businesses Plead to Access Federal Coronavirus Business Relief

A little over two months after the novel Coronavirus first appeared in Wuhan, China, it has spread to every continent except Antarctica and left over 10,000 people dead in its wake. The World Health Organization has declared the virus a pandemic, and it’s safe to say most of us haven’t experienced anything of this magnitude in our lifetimes. Fearing an outbreak of black plague proportions, most countries have been going into lockdowns to prevent the spread of the virus.

However, while social distancing and self-isolation have been found to be the best preventive measures, the long term effect it could have on the economy is catastrophic, especially if the lockdowns last a while. Businesses all over the country are already feeling the pinch, and to help alleviate this, the U.S. federal government has pledged to provide financial assistance to keep the economy going in these trying times.

This has left the cannabis industry between a rock and a hard place. Cannabis businesses are required to comply with Coronavirus related measures that will without a doubt affect their cash flows, but since cannabis is still illegal at the federal level, they will not have access to federal business relief. On Friday, a coalition of major cannabis industry associations sent a letter to the leaders of the House and Senate asking them to ensure cannabis businesses qualify for assistance.

“Our members follow strict regulations, create jobs, generate millions of dollars in tax revenue, including federal corporate tax revenue, and act as good corporate citizens, yet it appears as if these businesses will not be eligible for the same loans available to other businesses in this country at rush due to the global pandemic,” states the letter.

It was jointly sent by the National Cannabis Industry Association, National Cannabis Roundtable, Minority Cannabis Business Association, Global Alliance for Cannabis Commerce and Cannabis Trade Federation.

“The ineligibility of cannabis businesses for disaster assistance loans is especially inequitable given that these same cannabis businesses are required to comply with other Coronavirus related measures. We are not seeking special treatment for state-legal cannabis businesses. We only seek to have them treated on an equal level as all other job-generating, tax-paying companies in this country.”

Non-profit group NORML has suggested that the Families First Coronavirus Response Act could help extend some benefits to the legal marijuana industry which employs an estimated 240,000 people in the U.S. Signed into law this week, the act directs federal funds to state governments to help them deal with the pandemic.

After conferring with experts, NORML believes the act “provides the individual states with authority to decide for themselves which industries are legally eligible to receive benefits.”

The group has stated that it will “continue to work with our federal allies to call for an end for such discriminatory practices against the cannabis industry and those whose livelihoods depend upon it.”

Analysts agree that cannabis sector players like ChineseInvestors.com Inc. (OTCQB: CIIX) are feeling the full impact of the economic slowdown resulting from the Coronavirus outbreak, so it is only fair that any relief available to other industries should also be accessible by the legal marijuana industry.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Is Marijuana Use Advisable During Coronavirus Quarantine?

At the moment, millions of people all over Asia, the U.S. and Europe have been forced into self-isolation. In the few months that it has been active, the Coronavirus has wreaked havoc, with more than 300,000 people infected and at least 12,944 dead, according to a tally by Johns Hopkins University. The virus is very communicable, and the best preventive measures are self-isolation and social distancing.

However, that’s easier said than done. And for those who aren’t used to working from home or long periods of isolation, it’s going to be quite tough. As more and more U.S. states go into lockdown to curb the spread of the condition, there has been a spike in demand for marijuana as people stock up. There is plenty of evidence that marijuana can help reduce stress levels and anxiety, and it could be the perfect companion during a long period of isolation.

Researchers have found that high-CBD/high-THC strains reduce stress while high-CBD/low-THC strains help limit depression. If you’re planning on using marijuana to help cope with the anxiety and stress of self-isolation, here are a few things you should keep in mind.

For starters, if you’re smoking with other people, do not share joints, pipes, bongs, vape pens, or anything that will touch your lips. “Community has always been central to cannabis culture, but given the health crisis we find ourselves in, it is best we think of community a little differently,” says Erik Altieri, Executive Director of the National Organization for Reform of Marijuana Laws. He suggests moving any group sessions to FaceTime, Zoom or Skype.

Secondly, make sure you keep your smoking equipment clean. A study conducted by Moose Labs, a Los Angeles-based cannabis accessories company, found that cannabis equipment can collect a staggering amount of germs. According to co-founder Jay Rush, the average gas station toilet has about 900 bacteria per square inch, while the average bong has about 3,000 bacteria per square inch.

Altieri says to regularly clean and disinfect your equipment with high percentage isopropyl alcohol (rubbing alcohol) to ensure they stay sterile.

Lastly, experts advise against smoking as it affects lung health. The Coronavirus attacks respiratory systems, and smoking puts you at greater risk. New York City Mayor, Bill de Blasio, recently stated that smokers and vapers are indeed more vulnerable to the Coronavirus. “If you are a smoker or a vaper, this is a very good time to stop that habit,” he said.

Instead, opt for edibles, oils, and tinctures as they don’t need to be combusted and inhaled. If you’re a little adventurous, there are plenty of marijuana recipes that are sure to keep you busy.

The entire cannabis industry, including companies like HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF), is hoping that people adhere to all the recommendations provided by health experts so that everyone can come out of this crisis stronger.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) CEO Shares Strategic Goals in Exclusive Audio Interview

Champignon Brands (CSE: SHRM), a wellness company specializing in medicinal mushroom and mushroom-infused products, today announced the broadcast of its audio interview with NetworkNewsAudio (“NNA”), one of 40+ brands in the InvestorBrandNetwork (“IBN”). In the interview, Champignon Brands CEO Gareth Birdsall joins NNW’s Stuart Smith to delve into the company’s strategic plan to expand its portfolio and become a preeminent player in the emerging psychedelic medicine arena. “We’ve achieved some pretty impressive sales from around the globe, revamped our e-commerce website, as well as commenced certain research and development initiatives,” Birdsall said, noting Champignon recently completed an initial public offering and is planning to achieve listings in Frankfurt, Germany and on the OTC marketplace in the U.S.

To view the full press release, visit http://cnw.fm/0pPyx

About Champignon Brands Inc.

Champignon Brands Inc. (CSE: SHRM) is a Canadian based company dedicated to the distribution of artisanal medicinal mushrooms infused products. The Champignon team is mandated with enhancing the health and wellness of millions of potential consumers through the distribution of a premium, mushroom-infused product suite. Champignon continues to be inspired by sustainability, as all of its eligible SKUs are organic, non-GMO and vegan certified. For more information, visit www.Champignonbrands.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://cnw.fm/SHRM

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces Expansion of Pharmaceutical Division to Include Lipophilic Antiviral Active Molecules for COVID-19 Treatment

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced expansion of the scope and activities of its 100%-owned subsidiary Lexaria Pharmaceutical Corp. According to the update, Lexaria Pharmaceutical will investigate how the company’s patented DehydraTECH(TM) drug delivery technology could enhance delivery and effectiveness of certain antiviral drugs in the fight against coronavirus disease COVID-19. Lexaria intends to expand collaboration with leading laboratories across North America and internationally as soon as possible.

To view the full press release, visit http://cnw.fm/4NW8h

About Lexaria

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXX

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CBDNewsBreaks – Marijuana Company of America, Inc.’s (OTCQB: MCOA) hempSMART Offers Important Information for Immune Support, Significant Price Reduction for CBD Drops

Marijuana Company of America (OTCQB: MCOA), an innovative hemp and cannabis corporation, today announced that its subsidiary, hempSMART(TM), will offer products to consumers at a substantial savings. In today’s climate of concern about immune system health, Chairman of hempSMART’s Medical Advisory Board, Paula Vetter FNP, stated, “maintaining a healthy immune system requires a multi-faceted approach. Along with common sense measures like social distancing and hand washing, we can enable our immune system to function optimally by specifically supporting our Endocannabinoid System with a quality CBD product.”

To view the full press release, visit http://cnw.fm/F3Oap

About Marijuana Company of America Inc.

MCOA is a corporation that participates in: (1) product research and development of legal hemp-based consumer products under the brand name hempSMART(TM), which targets general health and well-being; (2) an affiliate marketing and retail sales program to promote and sell its legal hemp-based consumer products containing CBD; (3) joint ventures and acquisitions of business entities engaged in the growth and sale of hemp and cannabis products in jurisdictions where cultivation is legal; and (4) the expansion of its business into ancillary areas as market opportunities in this segment mature and develop. For more information, visit www.MarijuanaCompanyofAmerica.com.

NOTE TO INVESTORS: The latest news and updates relating to MCOA are available in the company’s newsroom at http://cnw.fm/MCOA

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

CBDNewsBreaks – No Borders, Inc.’s (NBDR) MediDent Begins Air Freight Shipments of Medical Supplies into the U.S.

No Borders (OTC: NBDR) on Friday announced that its subsidiary, MediDent Supplies, has begun expedited air freight shipments of medical equipment and supplies into its operations center in Phoenix, Arizona. Due to national demand for medical equipment such as ventilators, respirators, touchless thermometers, and autoclaves as well as municipal and hospital demand for PPE and disposables such as DTC3X-N95 surgical masks, SMS isolation gowns, latex & nitrile gloves, and ammonia disinfectant wipes, in addition to the recent launch of the Company’s “MediDent Supplies Viral Specimen Collection Kit” to support the #StayHomeSaveLives efforts across the country, MediDent executives determined that expediting delivery of these items to its distribution facility to begin filling immediate volume demands would serve the national interest while positively impacting the Company’s revenues. “Even with the investments, our Board approved before COVID-19 took hold in the USA we have simply been overwhelmed with demand for testing, PPE gear and many other items,” MediDent Supplies CEO Joseph Snyder said in the news release. “While we have been able to continue delivering to new and existing customers so far, these efforts to quickly bring large volumes of items to market while expanding our product lines based on the needs of municipal and healthcare groups will increase the impact our company has and the growth of shareholder value. Not even a week ago we talked about managing the spike in demand for medical equipment and today our company has multiple additional products such as surgical masks and isolation gowns being flown in for immediate distribution.”

To view the full press release, visit http://cnw.fm/Hzqe9

About No Borders Inc.

No Borders Naturals Inc., a purveyor of health and wellness products for active consumers and their pets (NoBordersNaturals.com).
No Borders Labs Inc., which provides leading-edge tech tools to NBDR internal companies while also offering consulting, architecture and software development services to external businesses looking to update their technology infrastructure for greater efficiency, security, and transparency (NoBordersLabs.com).
CBDLabChain.com a powerful, Patent Pending tool to demonstrate in an unbiased and unchangeable way a clear sense of security to consumers of CBD products by recording Certificate of Authority (COA) on a blockchain technology platform.
No Borders Dental Resources Inc., a provider of equipment and supplies to medical and dental professionals across the U.S. through the trade name MediDent Supplies (MediDentSupplies.com).

No Borders is headquartered in Arizona with resources in the U.S., South America, Asia, and Europe. For more information, visit the Company’s website at www.NBDR.co.

NOTE TO INVESTORS: The latest news and updates relating to NBDR are available in the company’s newsroom at http://cnw.fm/NBDR

About CBDWire

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

420 with CNW – New York Legislators File Revised Cannabis Legalization Bill

Compared to other states, cannabis legalization efforts in New York have been slow. Both hemp and marijuana bills have been held up in various stages of the legalization process, and the emergence of the coronavirus has thrown a wrench into the works. For instance, Governor Cuomo had been planning on carrying out benchmarking visits to legal cannabis states, but he has stated that the tour has been delayed as the country deals with the coronavirus pandemic.

However, there is still a glimmer of hope after lawmakers recently rolled out a revised bill to legalize marijuana in the state. Filed last week on Thursday, the bill would allow individuals 21 and over to purchase cannabis from licensed retailers and grow up to six plants for personal use.

Cannabis sales would be subject to an 18% tax which will be used to cover the costs of implementation. The remainder will go towards three areas: 25% will go to a state lottery fund designated for the Department of Education, 25% will be used for a drug treatment and public education fund, and 50% will go to a community grants investment fund.

Governor Cuomo has in the past stated that the budget should be the vehicle to enact reform, and he has included legalization in his budget proposal for the second year in the row. And despite the current state of world affairs, he has insisted that pushing reform through the budget is the best way to move forward.

Melissa Moore, New York deputy state director of the Drug Policy Alliance states that in an ideal world, language from the revised bill would be inserted into the budget before it arrives at Governor Cuomo’s desk. “But that prospect seems dimmed in light of the current crisis, which has shifted legislative priorities,” Moore says.

“We have to make the political decisions. The budget is the time to make the political decisions,” stated Governor Cuomo, adding that “without the budget, the easiest thing for a legislative body to do is to do nothing.”

The measure hasn’t received overwhelming support, with some wondering whether the bill will be passed in its entirety. According to Senate Deputy Leader Mike Gianaris, issues like marijuana reform could be delayed as lawmakers ‘try to be incredibly effective this week, to only come in as necessary.’

“I think at this point it’s pretty unlikely that adult-use moves in the expedited budget the NY legislature is working on. Sounds like they’re focusing on essential items and policy provisions like this are falling out as they try to close the budget by Friday,” says Moore.

The Senate version of the bill is currently sitting at the Finance Committee and the Assembly version is in the Codes Committee.

It would be interesting to hear what sector players like Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) have to say about this latest move to legalize marijuana legislatively in New York State.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.